Back to Results
First PageMeta Content
Immune system / Tolerx / Health / Immunology / Autoimmune disease / Autoimmunity


For internal review only: Draft as of March 23, 2015 Lycera Announces Milestone in Merck Collaboration NEW YORK and ANN ARBOR, Mich., Mar. 25, Lycera Corp., a biopharmaceutical company developing breakthrough me
Add to Reading List

Document Date: 2015-03-31 10:51:59

Open Document

File Size: 233,02 KB

Share Result on Facebook

City

ANN ARBOR / NEW YORK / /

Company

InterWest Partners / ARCH Venture Partners / Clarus Ventures / Lycera Corp. / Merck Collaboration NEW YORK / EDF Ventures / /

Country

United States / Canada / /

Currency

USD / /

Event

Business Partnership / Funding / /

IndustryTerm

therapies for autoimmune disorders / treatment of inflammatory bowel disease / biopharmaceutical / treatment of cancer / biopharmaceutical company developing breakthrough medicines / diverse applications / /

MedicalCondition

autoimmune disorders / inflammatory bowel disease / cancer / immune-mediated disorders / autoimmune disease / diverse disease / autoimmune diseases / /

MedicalTreatment

small molecule therapies / /

Person

Paul Sekhri / /

Position

President and CEO / /

ProvinceOrState

Michigan / /

Technology

drug discovery / cell signaling / /

URL

www.lycera.com / /

SocialTag